Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
about
Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneityPPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsMetformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer CellsDiabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression.Research Resource: A Dual Proteomic Approach Identifies Regulated Islet Proteins During β-Cell Mass Expansion In Vivo.Chloride intracellular channel 1 regulates the antineoplastic effects of metformin in gallbladder cancer cells.Modulation of the inwardly rectifying potassium channel Kir4.1 by the pro-invasive miR-5096 in glioblastoma cellsIn vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsThe broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosineCLIC1 Inhibition Attenuates Vascular Inflammation, Oxidative Stress, and Endothelial Injury.The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma.Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells.Suppression of 14-3-3γ-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells.Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells.Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cellsTumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams.Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches.Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.Advances in β cell replacement and regeneration strategies for treating diabetesStattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cellsMetformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells.Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors.Identification of Potent Chloride Intracellular Channel Protein 1 Inhibitors from Traditional Chinese Medicine through Structure-Based Virtual Screening and Molecular Dynamics Analysis.Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes.Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects.The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell ViabilityDrug Repurposing of Metabolic Agents in Malignant GliomaCombined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
P2860
Q26796292-CD1288A8-9D3C-4013-A432-E9EA1FDCD083Q28066756-1BB92AE3-F673-46CA-99FC-140BAF4658C8Q28547140-9D29BB8C-7C83-46BA-8343-584AA74B74D0Q33591379-0533076A-C241-41DE-BABE-4D0D315BA3D6Q33631454-C9970676-95AB-45C9-BFDB-D0345E8FF27DQ33823195-BC9675A3-DA2B-4411-8B0C-E9950E6062BEQ33914091-10AA02C9-5F4D-4132-B230-DE592513D6D8Q35425337-1BAE80D1-6E5A-411B-A099-45E1AC03823DQ35741522-43FE7E6C-AB02-4E05-847C-CF70D3A9E328Q35987417-3073A2C3-A91E-45D0-8B7E-45E1B89D3DC0Q36197592-CB1BBD81-2DE0-4F93-A1A4-561D7B9C940DQ36232092-F7D68D7B-AC58-4A9D-BFDA-03EF38EC0EBAQ36413835-D99E050F-6A36-46C6-9B73-DF1CCF895D27Q36545028-9744AEF4-44D4-4713-895F-CB43C7D14C04Q36741098-D9664362-B2A1-4AC7-B331-95BF540CCA10Q36925343-DD11FA48-7E5A-4FD6-8CF7-90B59A6C5515Q37118676-7457DC81-FFA8-4B70-A377-0F18A044E69AQ37274957-FA6CA9FF-CB17-4CB9-B3CC-A9B429C8439AQ37368670-B6840506-13E2-4303-8DFD-7C89D5E109C3Q37437614-F16009F4-CE63-4A69-8D90-B9E0AAC21D32Q37649057-F910B568-AB38-4819-A10B-48E05709452AQ37697040-BB4D6435-60C4-4BC0-8EB4-8D4E10199DE7Q38704618-817DE56A-CC7C-42EA-A8BF-028DBD014A22Q38711927-96C20E4A-F4F5-4B78-9115-2CAB9BF20904Q38819651-3FAB5975-432E-4278-B75B-CA5E440CEBE8Q38885892-CD8CD17E-1725-41D7-8548-D743B46FF4A7Q38970248-360DD6AE-DEAD-4E11-81F4-AB24914F63FDQ39057993-FD22C5F4-AC3C-451D-9274-D171C8A8A34EQ42038363-E26BEC0A-F941-4D73-BB79-2CFE31626A0CQ42272463-3753F57B-40DF-44AA-9342-D23248520699Q42316246-B4AD8D15-6314-4920-ACB9-F17AA33DBE87Q45787651-37884791-8E7C-4F69-A0AB-789432E5512FQ47109280-D8954C8B-3D0B-4882-B9A7-99AFB4B4079EQ48116589-724F493D-66AF-427E-AC85-39D20B25B304Q48190503-1F1A0FEE-AFD9-4C70-AD8A-608A576AD0DEQ52676408-EE72A586-5C17-4E93-90DE-8F74F2D0C9BDQ57117113-1DE70F3C-2616-4135-988C-74DBD30323E0Q58728819-0F303565-2663-492C-85E0-A4AEB50054AFQ58738611-F1F07100-63B6-46CE-B61F-534EF1207499Q58779141-9497D1F4-9096-4FFA-BE24-370746BBAAEA
P2860
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metformin repositioning as ant ...... of CLIC1-mediated ion current
@ast
Metformin repositioning as ant ...... of CLIC1-mediated ion current
@en
Metformin repositioning as ant ...... of CLIC1-mediated ion current
@nl
type
label
Metformin repositioning as ant ...... of CLIC1-mediated ion current
@ast
Metformin repositioning as ant ...... of CLIC1-mediated ion current
@en
Metformin repositioning as ant ...... of CLIC1-mediated ion current
@nl
prefLabel
Metformin repositioning as ant ...... of CLIC1-mediated ion current
@ast
Metformin repositioning as ant ...... of CLIC1-mediated ion current
@en
Metformin repositioning as ant ...... of CLIC1-mediated ion current
@nl
P2093
P2860
P50
P356
P1433
P1476
Metformin repositioning as ant ...... of CLIC1-mediated ion current
@en
P2093
Alessandra Pattarozzi
Elisa Carra
Erika Pizzi
Federica Barbieri
Marina Angelini
Marta Gritti
Marta Peretti
Paul M G Curmi
Rodolfo Sirito
P2860
P304
11252-11268
P356
10.18632/ONCOTARGET.2617
P407
P577
2014-11-01T00:00:00Z